Vireo Growth (VREOF) Operating Margin (2020 - 2026)
Vireo Growth (VREOF) posted Operating Margin of 8.47% for Q1 2026, up 588.13% sequentially from 1.74% in Q4 2025, and up 31.0% YoY from 6.47% in Q1 2025.
Vireo Growth (VREOF) Operating Margin (2020 - 2026) Analysis & Trends
Vireo Growth has reported Operating Margin for 7 years, with the latest figure at 8.47% in Q1 2026.
- Quarterly Operating Margin rose 31.0% year-over-year to 8.47% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.71% (down 912.0% YoY) and the FY2025 annual result came in at 0.39%, down 1404.0% from the prior year.
- Operating Margin improved to 8.47% in Q1 2026 per VREOF's latest filing, from 1.74% in the prior quarter.
- Over five years, Operating Margin peaked at 23.8% in Q3 2023 and troughed at 49.62% in Q1 2022.
- A 5-year average of 3.75% and a median of 1.93% in 2023 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2022 and 2025: Operating Margin surged 6416 bps in 2022, then plunged 2728 bps in 2025.
- Over 5 years, Operating Margin stood at 3.69% in 2022, then surged by 504 bps to 22.26% in 2023, then slumped by 115 bps to 3.36% in 2024, then soared by 48 bps to 1.74% in 2025, then jumped by 588 bps to 8.47% in 2026.
- According to Business Quant data, Operating Margin over the past three periods registered 8.47%, 1.74%, and 0.88% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Vireo Growth | 491.44 Mn | 349.14 Mn | 95.30 Mn | -3.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.47% |
| Dec 31, 2025 | -1.74% |
| Sep 30, 2025 | 0.88% |
| Jun 30, 2025 | -4.20% |
| Mar 31, 2025 | 8.16% |
| Dec 31, 2024 | -3.36% |
| Sep 30, 2024 | 15.30% |
| Jun 30, 2024 | 23.08% |
| Mar 31, 2024 | 19.76% |
| Dec 31, 2023 | 22.26% |
| Sep 30, 2023 | 23.80% |
| Jun 30, 2023 | -5.16% |
| Mar 31, 2023 | 1.93% |
| Dec 31, 2022 | 3.69% |
| Sep 30, 2022 | -1.00% |
| Jun 30, 2022 | 1.46% |
| Mar 31, 2022 | -49.62% |
| Dec 31, 2021 | -60.47% |
| Sep 30, 2021 | -30.90% |
| Jun 30, 2021 | -22.82% |